» Articles » PMID: 37047821

A Method and Formula for the Quantitative Analysis of the Total Bioactivity of Natural Products

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2023 Apr 13
PMID 37047821
Authors
Affiliations
Soon will be listed here.
Abstract

Identification of bioactive natural products from plants starts with the screening of extracts for a desired bioactivity such as antimicrobial, antifungal, anti-cancer, anti-inflammatory, or neuroprotective. When the bioactivity shows sufficient potency, the plant material is subjected to bio-activity-guided fractionation, which involves, e.g., sequential extraction followed by chromatographic separation, including HPLC. The bioactive compounds are then structurally identified by high-resolution mass spectrometry and nuclear magnetic resonance (NMR). One of the questions that come up during the purification process is how much of the bioactivity originally present in the crude extract is preserved during the purification process. If this is the case, it is interesting to investigate if the loss of total bioactivity is caused by the loss of material during purification or by the degradation or evaporation of potent compounds. A further possibility would be the loss of synergy between compounds present in the mixture, which disappears when the compounds are separated. In this publication, a novel formula is introduced that allows researchers to calculate total bioactivity in biological samples using experimental data from our research into the discovery of anti-inflammatory compounds from (Grey Myrtle). The results presented show that a raw ethanolic extract retains slightly more bioactivity than the sum of all sequential extracts per gram of starting material and that-despite a large loss of material during HPLC purification-the total bioactivity in all purified fractions is retained, which is indicative of rather an additive than a synergistic principle.

Citing Articles

Plant Extracts from the Yucatan Peninsula in the In Vitro Control of and Antifungal Effect of and Extracts on Postharvest Fruits of Habanero Pepper.

Cruz-Cerino P, Cristobal-Alejo J, Ruiz-Carrera V, Gamboa-Angulo M Plants (Basel). 2023; 12(16).

PMID: 37631120 PMC: 10459550. DOI: 10.3390/plants12162908.


From the Bush to the Brain: Preclinical Stages of Ethnobotanical Anti-Inflammatory and Neuroprotective Drug Discovery-An Australian Example.

Kumar P, Mathew S, Gamage R, Bodkin F, Doyle K, Rossetti I Int J Mol Sci. 2023; 24(13).

PMID: 37446262 PMC: 10342267. DOI: 10.3390/ijms241311086.

References
1.
Singh A, Raju R, Mrad M, Reddell P, Munch G . The reciprocal EC value as a convenient measure of the potency of a compound in bioactivity-guided purification of natural products. Fitoterapia. 2020; 143:104598. DOI: 10.1016/j.fitote.2020.104598. View

2.
Turpin G, Ritmejeryte E, Jamie J, Crayn D, Wangchuk P . Aboriginal medicinal plants of Queensland: ethnopharmacological uses, species diversity, and biodiscovery pathways. J Ethnobiol Ethnomed. 2022; 18(1):54. PMC: 9364609. DOI: 10.1186/s13002-022-00552-6. View

3.
Zhou X, Seto S, Chang D, Kiat H, Razmovski-Naumovski V, Chan K . Synergistic Effects of Chinese Herbal Medicine: A Comprehensive Review of Methodology and Current Research. Front Pharmacol. 2016; 7:201. PMC: 4940614. DOI: 10.3389/fphar.2016.00201. View

4.
Sharma S, Gupta R . Drug development from natural resource: a systematic approach. Mini Rev Med Chem. 2015; 15(1):52-7. DOI: 10.2174/138955751501150224160518. View

5.
Thakur M, Vasudeva N, Sharma S, Datusalia A . Plants and their Bioactive Compounds as a Possible Treatment for Traumatic Brain Injury-Induced Multi-Organ Dysfunction Syndrome. CNS Neurol Disord Drug Targets. 2022; . DOI: 10.2174/1871527321666220830164432. View